XIENCE XPEDITION 1074300-08Recalls & reported problems
Abbott Vascular Inc. · XIENCE Xpedition Everolimus Eluting Coronary Stent System 3.00 mm x 8 mm / Rapid-Exchange · Class 3 · Implant
All models of XIENCE XPEDITION (41)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 1
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648162312), received between Jan 23, 2017 and Jan 23, 2017 — classified as 1 death.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Death1
- Ischemia1
- Prolapse1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
DeathJan 23, 2017Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT LESIONS LOCATED IN THE LEFT MAIN AND PROXIMAL LEFT ANTERIOR DESCENDING CORONARY ARTERIES ON (B)(6) 2016. AFTER ABLATION WAS PERFORMED WITH A NON-ABBOTT DEVICE, A PERFORATION OCCURRED. NON-ABBOTT STENTS WERE IMPLANTED TO TREAT THE PERFORATION. THEN, TWO XIENCE XPEDITION (3.0 X 38 MM AND 3.0 X 8 MM) STENTS WERE IMPLANTED. AFTER IMPLANTATION OF THE XIENCE XPEDITION STENTS, BLOOD FLOW WAS DECREASED AND THE PATIENT'S CONDITION CHANGED FOR THE WORSE. IN SPITE OF INTRA-AORTIC BALLOON PUMP (IABP) AND PERCUTANEOUS CARDIO PULMONARY SUPPORT (PCPS) FOLLOWED BY CORONARY ARTERY BYPASS GRAFT (CABG), ON (B)(6) 2016, THE PATIENT EXPIRED. THE CAUSE OF DEATH WAS REPORTED AS HEART FAILURE DUE TO THE DECREASED BLOOD FLOW CAUSED BY PLAQUE, HOWEVER IT COULD NOT BE CONFIRMED WHEN THE PLAQUE SHIFT OCCURRED; AFTER IMPLANT OF ONE OR BOTH STENTS. NO ADDITIONAL INFORMATION CAN BE PROVIDED.
Patient problems: Death; Ischemia; Prolapse
MAUDE report 6271746 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page